IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will release third quarter 2006 financial results on November 2, 2006, before the U.S. markets open. ISTA will host a conference call with a simultaneous webcast to discuss these results at 10:30 AM Eastern Time on November 2, 2006.
To access the live conference call, U.S. and Canadian participants may dial 800-259-0251; international participants may dial 617-614-3671. The access code for the live call is 96443330. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 39734472. This conference call also will be webcast live and archived on ISTA’s website for 30 days at www.istavision.com.
ABOUT ISTA
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA’s products addressing the $3.2 billion prescription ophthalmic industry include therapies for allergy, dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, ocular pain, and inflammation. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company’s product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals’ website at www.istavision.com.
ISTA Pharmaceuticals, Inc.
CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals; or Justin Jackson, Media, jjackson@burnsmc.com, or JulianeSnowden-Andrew, Investors, jsnowden-andrew@burnsmc.com, both of BurnsMcClellan, +1-212-213-0006
Web site: http://www.istavision.com/
